Business · 10/06/2011Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Information for In Vivo Radiopharmaceuticals
Summary
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to in vivo radiopharmaceuticals used for diagnosis and monitoring, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Health and Human ServicesOpen original release →